Malignant Superior Sulcus Neoplasm — Trials

Malignant Superior Sulcus Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Fundación GECP
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05684276	DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors(DUMAS)	active not recruiting	Phase 2	22	Fundación GECPOTHER	1	May 5, 2026	clinicaltrials
NCT04989283	Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer	withdrawn	Phase 2	0	National Cancer Institute (NCI)NIH	1	Sep 26, 2023	clinicaltrials